In accordance with law and industry standards, Memorial Sloan Kettering Cancer Center (MSK) maintains an active and enforced institutional process for the disclosure, adjudication, and management of situations in which faculty and other individuals in positions of responsibility have a personal financial interest that could influence decisions they make on behalf of MSK or research conducted at MSK.

The Evidence-based Cancer Imaging Program (ECIP) has established an additional conflict of interest process specifically for the PAMA mandate that has been integrated into MSK’s institutional conflict of interest disclosure process and system. As required by CMS, this process identifies potential conflicts of interest of individuals (or the spouse or dependent child of individuals) who have substantively participated in the development, modification or endorsement of appropriate use criteria (AUC) and could financially benefit from the AUC. The information collected through this process is documented and will be supplied in a timely fashion in response to a request from the public. The information will be available for a period of not less than five years after the most recent published update of the relevant AUC.

In the event that a potential conflict of interest related to the development, modification or endorsement of AUC is identified, the participant disclosure form will be reviewed by the MSK Compliance Office, ECIP Program Manager and the Imaging Disease Management Team lead. The outcome of the review may result in the recusal or exclusion of individuals from the AUC process as appropriate.

Visit the MSK Conflict of Interest policy page to learn more.

Last updated on 10/19/2020